BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased C3.ai, Inc. ("C3.ai†or the "Company†) (NYSE: AI) securities between February 26, 2025 and August 8, 2025, inclusive (the "Class Period†). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN C3.AI, INC. (AI), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FR. ...

CLASS PERIOD: February 26, 2025 to August 8, 2025 ALLEGATIONS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of C3 AI's growth; notably, that its Chief Executive Officer health was having a significant impact on the Company's ability to close deals, that its management was unable or otherwise ineffectual in mini ...

Core Insights - The information technology sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator for identifying oversold conditions, with a value below 30 indicating potential buying opportunities [1] Company Summaries - **Accenture Plc (ACN)**: - Recently acquired IAMConcepts, a Canadian IAM services company - Stock has decreased approximately 26% over the past six months, with a 52-week low of $236.67 - Current RSI value is 28, and shares closed at $243.11 after a 3.5% drop [7] - **C3.ai Inc (AI)**: - Missed first-quarter earnings estimates and provided weak guidance - Stock fell around 5% in the past month, with a 52-week low of $14.70 - Current RSI value is 28, and shares closed at $15.61 after a 0.8% decline [7] - **Endava PLC (DAVA)**: - Reported mixed quarterly results, with a focus on AI integration in projects - Stock has decreased approximately 24% over the past month, with a 52-week low of $9.36 - Current RSI value is 25.7, and shares closed at $9.40 after a 5.3% drop [7]

Core Insights - The information technology sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator for identifying oversold conditions, with a value below 30 indicating that a stock may be oversold [1] Company Summaries - **Accenture Plc (ACN)**: - Recently acquired IAMConcepts, a Canadian company specializing in identity and access management services - Stock has fallen approximately 26% over the past six months, with a 52-week low of $236.67 - Current RSI value is 28, and shares closed at $243.11 after a 3.5% decline [7] - **C3.ai Inc (AI)**: - Missed first-quarter earnings estimates and provided weak guidance - Stock has decreased around 5% over the past month, with a 52-week low of $14.70 - Current RSI value is 28, and shares closed at $15.61 after a 0.8% decline [7] - **Endava PLC (DAVA)**: - Reported mixed quarterly results, with a focus on AI integration among clients - Stock has dropped approximately 24% over the past month, with a 52-week low of $9.36 - Current RSI value is 25.7, and shares closed at $9.40 after a 5.3% decline [7]

C3.ai, Inc. (NYSE:AI) is one of the Hot AI Stocks to Keep on Your Radar. On September 9, the company announced C3 AI Agentic Process Automation, a new product that leverages autonomous AI agents to handle business and operational workflows across enterprises. The C3 AI Agentic Process Automation handles numerous types of business processes such as order-to-cash, customer service, invoice processing, debt collection, supplier onboarding, procurement, and employee onboarding, industrial operations, manufact ...

Core Viewpoint - C3.ai, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding its growth and the impact of its CEO's health on the company's performance [3][4]. Summary by Relevant Sections Allegations - The complaint claims that C3.ai's management provided overly positive statements while concealing material adverse facts about the company's growth, particularly the CEO's health affecting deal closures [3]. - The company announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health [3]. Stock Price Impact - Following the announcement on August 8, 2025, C3.ai's stock price dropped from $22.13 per share to $16.47 per share by August 11, 2025, marking a decline of approximately 25.58% in just one day [3]. Class Action Details - Shareholders who purchased shares during the class period from February 26, 2025, to August 8, 2025, are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for October 21, 2025 [4]. - Participants will be enrolled in a portfolio monitoring system to receive updates throughout the case [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5].

Key Takeaways C3.ai has dropped 36.2% in three months, sharply underperforming peers and the broader market. Revenues fell nearly 20%, margins slid to 52%, and the full-year guidance was withdrawn. New CEO and restructured sales team aim to fix execution as big-name clients adopt C3.ai tech. C3.ai, Inc. ((AI) shares have been under pressure, sliding 36.2% over the past three months, steeper than the industry’s 8.5% decline. Over the same stretch, the S&P 500 has risen 9%, highlighting AI’s sharp underperfor ...

PHILADELPHIA, Sept. 10, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against C3.ai, Inc. (NYSE: AI) ("C3.ai" or the "Company") on behalf of investors who purchased or acquired shares during the period from February 26, 2025 through August 8, 2025(the "Class Period"). Accessibility StatementSkip Navigation WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+Newsrooms &Influencers 9k+Digital MediaOutlets 270k+JournalistsOpted In GET STARTED A ...

Core Viewpoint - A class action lawsuit has been filed against C3.ai, Inc. due to allegations of misleading investors regarding the impact of the CEO's health on the company's business prospects, leading to a significant drop in stock price following disappointing financial results [2][3]. Group 1: Allegations and Impact - The lawsuit claims that C3.ai failed to disclose how the CEO's health affected the company's ability to close deals and that management was ineffective in mitigating this impact [2]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health problems [2]. - Following this announcement, C3.ai's stock price fell from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of over 25% [2]. Group 2: Legal Proceedings - Shareholders wishing to serve as lead plaintiff in the class action must submit their papers to the court by October 21, 2025 [3]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [3]. Group 3: Company Background - Robbins LLP is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses and improve corporate governance since 2002 [4].

"We're focused on whether C3.ai's public statements were misleading in their failure to fully disclose how CEO Thomas M. Siebel's health was affecting the company's ability to close deals and meet financial targets," said Reed Kathrein, the Hagens Berman partner leading the investigation. Accessibility StatementSkip Navigation SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ -- A new class action lawsuit is targeting enterprise AI software company C3.ai (NYSE: AI) and its senior leadership, alleging they misled in ...